Safety and diagnostic efficacy of cone beam computed tomography-guided transbronchial cryobiopsy for interstitial lung disease: a cohort study. Issue 2 (6th August 2020)

• Record Type: Journal Article
• Authors: Zhou, Guowu; Ren, Yanhong; Li, Jun; Yang, Ting; Su, Nan; Zhao, Ling; Wang, Dan; Li, Ying; Tian, Zheng; Liu, Ruihong; Dai, Huaping; Wang, Chen
• Is Part Of: European respiratory journal. Volume 56:Issue 2(2020)
• Publication Date: 2020-08-06
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.00724-2020
• Languages: English
• ISSNs: 0903-1936

Abstract

Transbronchial cryobiopsy (TBCB) is one of the most important procedures for assessment of patients with suspected interstitial lung disease (ILD), when diagnosis cannot be made based on clinical and radiological assessments [1–4]. Recent reports suggested that TBCB may offer diagnostic value approaching that of surgical lung biopsy [5, 6]. Cone beam CT (CBCT) can provide 3-dimensional images enabling accurate positioning of cryoprobe. CBCT-guided transbronchial cryobiopsy had a favourable safety profile with low risks of pneumothorax and significant bleeding, with excellent diagnostic yield. https://bit.ly/2WF0SPF